文献速递甲状腺核医学放射性药物与辐射防护

颈动脉体瘤假阳性摄碘模拟分化型甲状腺癌淋巴结转移:SPECT/CT的鉴别价值

False-positive ¹³¹I Uptake in a Carotid Body Tumor Mimicking Nodal Metastasis in Differentiated Thyroid Carcinoma: Implications of Hybrid SPECT/CT.
PubMed 文献 · Clin Nucl Med · 2026-04-02

本文报道一名50岁女性滤泡变异型乳头状甲状腺癌患者,治疗后8年偶然发现颈动脉体瘤伴轻度摄碘,SPECT/CT将摄取定位于颈动脉体瘤而非淋巴结转移。该病例提示功能显像需与结构显像联合判读,避免将非特异性摄碘误判为转移而致不必要治疗。

要点

  • 颈动脉体瘤通常生长抑素受体显像阳性,而非摄碘阳性。
  • 分化型甲状腺癌随访中,摄碘灶需SPECT/CT定位排除假阳性。
  • 功能与结构显像联合可避免误判转移和不必要治疗。

核心结论

  • 颈动脉体瘤可表现为轻度摄碘的假阳性灶,模拟分化型甲状腺癌淋巴结转移。

研究设计与样本

  • 单病例报告:50岁女性滤泡变异型乳头状甲状腺癌,治疗后8年 incidental 发现颈动脉体瘤。

临床怎么用

  • 摄碘灶判读时应结合SPECT/CT定位,与结构影像对照,避免误判为转移。

局限性

  • 单病例报告,结论的外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Carotid body tumors (CBTs) are uncommon neuroendocrine neoplasms which typically demonstrate avidity on somatostatin receptor-based imaging rather than radioiodine studies. We report a 50-year-old woman with follicular variant papillary thyroid carcinoma who, eight years post-treatment, developed a CBT incidentally demonstrating mild radioiodine uptake. SPECT/CT localized this unexpected uptake to the CBT, representing a rare false-positive finding. This case underscores the importance of correlating functional imaging with structural imaging to avoid misinterpretation of nonspecific radioiodine uptake as metastatic disease and prevent unnecessary therapeutic interventions.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Kumar SA, Pandit N, Srinivasan P, et al. False-positive ¹³¹I Uptake in a Carotid Body Tumor Mimicking Nodal Metastasis in Differentiated Thyroid Carcinoma: Implications of Hybrid SPECT/CT. Clin Nucl Med. 2026. PMID: 41954972. doi:10.1097/RLU.0000000000006436

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。